|
|
2150 Woodward St., Suite 100 Austin, TX 78744 USA phone:1.877.777.1874 fax:1.512.681.5201
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.asuragen.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| A fully integrated RNA-based therapeutic and diagnostics company with a core focus on miRNA. |
 |
| Management |
| Matt Winkler, CEO/CSO; Rollie Carlson, President; Carol E. Berry, VP and General Manager of Services; Fred Fletcher, VP of Operations |
| |
|
|
| |
|
|
|
|
|
| Description |
|
Asuragen is a fully integrated RNA-based therapeutic and diagnostics company with a core focus on miRNA. Asuragen is leveraging its broad miRNA/mRNA IP portfolio to build a significant business focused on three product segments: microRNA therapeutics microRNA/mRNA molecular diagnostics Pharmacogenomic services |
 |
 |
|
|
|
|
|
|